Refine by
Genomic Profiling Equipment & Supplies
18 equipment items found
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
Targeted panel designed to detect actionable oncological targets in plasma. ...
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
648 gene panel + Whole transcriptome RNA sequencing with validated fusion detection, Enriched for clinically relevant genes and genes of emerging clinical relevance, Immunotherapy Metrics: MSI Status, Tumor Mutational Burden (TMB), IHC Options: Mismatch Repair (MMR), PD-L1 (22C3, SP142, and 28-8 clones), Available Add-on Tests: Tumor Origin (TO), Homologous Recombination Deficiency (HRD), DPYD ...
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
Tempus xE (version 2) is a whole exome next-generation sequencing assay that analyzes the entire coding region (exome) of the patient’s genome, combined with whole transcriptome RNA sequencing. Clinical sequencing is performed to 500x depth of coverage for tumor specimens and 150x for normal specimens for the clinically enhanced regions (648 genes). Non-enhanced regions are performed at ...
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Our DecisionDx-UMSeq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor genes may someday help guide treatment decisions. Because the amount of tumor biopsy tissue is limited, it is important to gain as much information as possible about a uveal melanoma tumor from a single ...
Manufactured by:Fusion Genomics Corporation based inBurnaby, BRITISH COLUMBIA (CANADA)
The goal of personalized medicine is to achieve optimal therapy for each patient based on his or her genomic profile. In infectious or host-dependent diseases, this means therapies that also take into account the pathogen’s mutating ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
This is a major advance over traditional chemotherapy, which can be as potent against healthy tissue as it is against cancer. Using tumor genomic profiling and biomarker strategies, physicians can select the patients most likely to respond well to targeted therapies. Yet, so far, due to exquisite selectivity of these new precision medicines, only relatively ...
Manufactured by:Guardant Health, Inc. based inRedwood City, CALIFORNIA (USA)
Our Guardant360® CDx test is FDA-approved for complete genomic testing across all solid cancers, providing doctors guideline-complete genomic results in 7 days from a simple blood draw to inform treatment decisions. A blood test does not require tissue testing, enabling more patients to benefit from the growing number of FDA-approved targeted therapies. ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Tissue specimens are either from surgical resections or biopsies which may raise the risk of bleeding, and infection and further require recovery from the procedure. Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The ...
by:CD Genomics based in, NEW YORK (USA)
Serial Analysis of Gene Expression (SAGE) is a powerful genome-wide expression profiling technology. Using the latest sequencing technologies, CD Genomics offers the most cost-effective outsourcing solution for both SAGETM and LongSAGETMlibraries construction and sequencing. ...
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
Celemics’ G-Mendeliome Clinical Exome Sequencing (CES) Panel is designed to overcome the limitations of analyzing clinical diseases with conventional whole-exome ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The SureSelect Target Enrichment System is the most proven target enrichment solution today. This technology enables the capture of genomic targets using long 120nt RNA baits which allow for efficient enrichment of regions of interest facilitating confident variant calling. The SureSelectQXT Reagent Kit is a combined shearing-free transposase-based library prep and target enrichment solution that ...
Distributed by:Discovery Scientific Inc based in, BRITISH COLUMBIA (CANADA)
SNP detection & SNP genotyping Gene expression ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Support treatment decisions with comprehensive tumor profiling. Gain deep insight into the tumor’s genomic alterations and oncology biomarkers with Altera. The detailed sequencing report includes FDA-approved treatments, novel treatment approaches and ongoing clinical trials targeting found mutations. Unlike any other tumor profiling ...
Manufactured by:OpGen, Inc. based inRockville, MARYLAND (USA)
Outbreak Surveillance and Infection Prevention require accurate typing and characterization of bacterial isolates. Sequence your isolates with the pathogenomics- and AMR-experts at Ares Genetics and rely on the validated, AI powered ARESiss platform for accurate, comprehensive, and epidemiologically relevant data from microbial isolates. ...
by:Oncodesign based inDijon, FRANCE
This is the best tool you can use to evaluate new therapeutic approaches in conditions that are as close as possible to a clinical situation: ...
Manufactured by:Thermo Scientific - LC/MS GC GC/MS based in, MASSACHUSETTS (USA)
Designed to make next-generation sequencing (NGS) accessible to clinical laboratories with all levels of sequencing expertise, the Ion Torrent Genexus Dx Integrated Sequencer delivers an effortless user experience while enabling regulatory ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
MTOB sodium is a potent C-terminal binding protein (CtBP) inhibitor. MTOB sodium attenuates repetitive head injury-elicited neurologic dysfunction and neuroinflammation via inhibition of the transactivation activity of CtBP1 and CtBP2. MTOB sodium antagonizes the transcriptional regulatory activity of CtBP1 and CtBP2 by eviction from their target promoters in breast cancer cell ...